The analysts’ positive stance on Intuitive Surgical is premised on its strong growth and profitability outlook. These analysts believe that the underlying demand for robotic surgery remains favorable. The current challenging issues for the company include lingering concerns about hospital capital spending, drop in procedure growth and stagnant da Vinci instrument average selling price (ASP). Still, these analysts remain positive about the company’s long-term outlook as the economy may stabilize and da Vinci’s usage increase across multiple specialties and indications. The analysts expect the company to boost its outside US (OUS) sales and marketing presence as more international markets adopt robotic surgery. In the end, the bullish analysts consider the company to be a safe investment despite quarter-to-quarter volatility.